연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2751. Mucosal associated invariant T cells in ARDS: MAIT cells set fire to macrophages via cytokines.
Kim DH, Kim B, Lee WW.
Thorax. 2022 Sep;77(9):846-847
Link
2750. Cytoplasmic zinc promotes IL-1β production by monocytes and macrophages through mTORC1-induced glycolysis in rheumatoid arthritis.
Kim B, Kim HY, Yoon BR, Yeo J, In Jung J, Yu KS, Kim HC, Yoo SJ, Park JK, Kang SW, Lee WW.
Sci Signal. 2022 Jan 11;15(716):eabi7400
Link
2749. Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer
Kim J, Jeong J, Lee CM, Lee DW, Kang CK, Choe PG, Kim NJ, Oh MD, Lee CH, Park WB, Lee KH, Im SA.
Frontiers in immunology 2022. 13:1028102.
Link
2748. Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment
Jinyong Kim1,, Euijin Chang1,, Song Yi Park, Dae-Won Lee, Chang Kyung Kang, Pyoeng Gyun Choe, , Nam Joong Kim, , Myoung-don Oh, Wan Beom Park, Kyung-Hun Lee, Seock-Ah Im
The oncologist 2022. 27(12):e931-e937
Link
2747. Glucose-Thymidine Ratio as a Metabolism Index Using 18F-FDG and 18F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy
Sera Oh 1 2 3, Hyewon Youn 1 3 4, Jin Chul Paeng 1 3, Young-Hwa Kim 1 3, Chul-Hee Lee 1 3, Hongyoon Choi 1 3, Keon Wook Kang 1 2 3 5, June-Key Chung 1 3, Gi Jeong Cheon 1 3
Int J Mol Sci. 2022 Aug 17;23(16):9273
Link
2746. Cerenkov luminescence imaging of interscapular brown adipose tissue using a TSPO-targeting PET probe in the UCP1 ThermoMouse
Seok-Yong Lee 1 2 3, Ho Rim Oh 1 2 3, Young-Hwa Kim 1 3, Sung-Hwan Bae 1 3, Yongseok Lee 4, Yun-Sang Lee 1 4 5, Byung Chul Lee 6 7, Gi Jeong Cheon 1 3, Keon Wook Kang 1 2 3, Hyewon Youn 1 3 4
Theranostics. 2022 Aug 29;12(14):6380-6394.
Link
2745. Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer
Sera Oh 1, Hobin Yang 2, Ho Rim Oh 1, Myeung-Ryun Seo 3, Chul-Hee Lee 4, Young-Hwa Kim 5, Jun Young Choi 6, Na Young Kim 6, Gi Jeong Cheon 5, Keon Wook Kang 7, Young Kee Shin 8, Hyewon Youn 9
Nucl Med Biol. 2022 Nov-Dec;114-115:135-142
Link
2744. Mitigating the BFL1-mediated antiapoptotic pathway in diffuse large B cell lymphoma by inhibiting HDACs
Park E, Lee C, Park J, Liu J, Hong J, Shin DY, Byun JM, Yun H, Koh Y, Yoon SS
Leuk Lymphoma. 2022 Nov 4:1-12
Link
2743. Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM
Park H, Byun JM, Yoon SS, Koh Y, Yoon SW, Shin DY, Hong J, Kim I
PLoS One. 2022 Jan 27;17(1):e0260113
Link
2742. Expansion of Human Megakaryocyte-Lineage Progeny via Aryl Hydrocarbon Receptor Antagonism with CH223191
Kim D, Shin DY, Liu J, Jeong NR, Koh Y, Hong J, Huang X, Broxmeyer HE, Yoon SS
Stem Cell Rev Rep. 2022 Dec;18(8):2982-2994
Link